150 related articles for article (PubMed ID: 1530905)
1. [Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
Gan To Kagaku Ryoho; 1992 Jan; 19(1):107-10. PubMed ID: 1530905
[TBL] [Abstract][Full Text] [Related]
2. [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
Toi M; Taniguchi T; Hayashi K; Tominaga T
Gan To Kagaku Ryoho; 1995 May; 22(6):799-804. PubMed ID: 7755388
[TBL] [Abstract][Full Text] [Related]
3. [5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer].
Yoshinaka K; Yagi M; Ohtagaki S; Toi M; Toge T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):115-8. PubMed ID: 1824814
[TBL] [Abstract][Full Text] [Related]
4. [A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
Maruyama S; Okumoto T; Kawasaki K; Ino H; Kanaya Y; Otani J; Yokoyama N; Soda M
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2235-8. PubMed ID: 11142168
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):973-7. PubMed ID: 11478147
[TBL] [Abstract][Full Text] [Related]
6. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
[TBL] [Abstract][Full Text] [Related]
7. [A case of intra-arterial infusion chemotherapy for liver metastases of breast cancer].
Yasui M; Yayoi E; Nishi T; Yamasaki M; Kishibuchi M; Yagyu T; Kawasaki K
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1963-6. PubMed ID: 10560437
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment of pleuritis carcinomatosa using combination therapy of 5'-DFUR, MPA and CPA as maintenance therapy].
Kiyono T; Nishiwaki M; Okuda K; Tsujitsuka K; Kano Y; Koga T; Ishimaru K; Goto T; Sumiyama M
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2087-90. PubMed ID: 10584577
[TBL] [Abstract][Full Text] [Related]
9. [A case of advanced breast cancer receiving combination therapy with 5'-DFUR and MPA with remarkable results].
Nishibe M; Kuribayashi H; Sato T; Watanabe I; Nishihara H
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1149-52. PubMed ID: 9239169
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
[TBL] [Abstract][Full Text] [Related]
11. [Combination therapy of doxifluridine (5'-DFUR) + cyclophosphamide (CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].
Ota J; Taguchi T; Sakai K; Irie K; Terasawa T; Shimoyama T; Kawahara T; Okumura T; Yamamoto M; Yasutake K
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1279-84. PubMed ID: 1386974
[TBL] [Abstract][Full Text] [Related]
12. [A case of breast cancer with liver metastases responding remarkably to combination therapy of mitoxantrone (MIT), doxifluridine (5'-DFUR) and medroxyprogesterone acetate (MPA)].
Fujitake S; Maeda Y; Shimizu M; Nozaki H; Tohyama M; Kataoka S
Gan To Kagaku Ryoho; 1999 Jul; 26(8):1177-80. PubMed ID: 10431585
[TBL] [Abstract][Full Text] [Related]
13. [A case of advanced breast cancer that responded remarkably to chemotherapy].
Watanabe Y; Kaiga T; Ueda T; Fujii M
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2113-6. PubMed ID: 11103244
[TBL] [Abstract][Full Text] [Related]
14. [A controlled study with medroxyprogesterone acetate (MPA) alone or in combination with cyclophosphamide (CPA) in the treatment of advanced or recurrent breast cancer unresponsive to other therapies. Osaka Study Group for the Treatment of Breast Cancer].
Aikawa T; Yayoi E; Takatsuka Y; Maeura Y; Miyauchi K
Gan To Kagaku Ryoho; 1991 May; 18(6):995-1002. PubMed ID: 1827575
[TBL] [Abstract][Full Text] [Related]
15. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
Noguchi S; Yamamoto H; Inaii H; Koyama H
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3555-8. PubMed ID: 2530936
[TBL] [Abstract][Full Text] [Related]
16. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
Satoh Y; Une Y; Fujisawa J; Uchino J
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2509-12. PubMed ID: 7944500
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action.
Kim R; Osaki A; Tanabe K; Kojima J; Toge T
Oncol Rep; 2001; 8(3):597-603. PubMed ID: 11295087
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer].
Takatsuka Y; Yayoi E; Miyauchi K; Aikawa T; Maeura Y; Hirai T; Kotsuma Y
Gan To Kagaku Ryoho; 1992 May; 19(5):631-6. PubMed ID: 1533755
[TBL] [Abstract][Full Text] [Related]
19. [A case of stage IV breast cancer showing long-term complete response to combination therapy with 5'-DFUR and MPA].
Kihara M; Matsusaka K; Miyauchi A; Maeda M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2123-6. PubMed ID: 9838917
[TBL] [Abstract][Full Text] [Related]
20. [A case of recurrent breast cancer with multiple lung, adrenal, inferior vena cava tumor thrombus and bone metastases successfully treated with 5'-DFUR and hormonal therapy].
Sakamoto E; Hasegawa H; Komatsu S; Hiromatsu T; Itazu K; Tabata T; Kawai K; Fukami Y
Gan To Kagaku Ryoho; 2005 Apr; 32(4):539-42. PubMed ID: 15853224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
